Nasopharyngeal carcinoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 12: | Line 12: | ||
**Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost | **Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost | ||
**[[Brachytherapy]] | **[[Brachytherapy]] | ||
Undifferentiated subtype of | Undifferentiated subtype of nasopharyngeal carcinoma is highly radiosensitive.<ref name="Weidner's">{{cite book |author=Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor) |title=Modern Surgical Pathology (2 Volume Set) |publisher=W B Saunders |location=London |year= |pages= |isbn=0-7216-7253-1 |oclc= |doi=}</ref> | ||
==References== | ==References== | ||
Revision as of 18:23, 16 September 2015
|
Nasopharyngeal carcinoma Microchapters |
|
Differentiating Nasopharyngeal carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nasopharyngeal carcinoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Nasopharyngeal carcinoma medical therapy |
|
Risk calculators and risk factors for Nasopharyngeal carcinoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
The mainstay of therapy for nasopharyngeal carcinoma is external beam radiotherapy, supplemented in some cases with chemotherapy.
Medical Therapy
- Standard treatments for patients with nasopharyngeal carcinoma include:[1]
- Radiation therapy alone
- Concurrent chemoradiation followed by adjuvant chemotherapy
- Chemotherapy alone for metastatic disease
- Treatments under clinical evaluation for patients with nasopharyngeal cancer include the following:[2]
- Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost
- Brachytherapy
Undifferentiated subtype of nasopharyngeal carcinoma is highly radiosensitive.[3]
References
- ↑ http://www.cancer.gov/types/head-and-neck/hp/nasopharyngeal-treatment-pdq#section/_50
- ↑ Tate DJ, Adler JR, Chang SD, Marquez S, Eulau SM, Fee WE; et al. (1999). "Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control". Int J Radiat Oncol Biol Phys. 45 (4): 915–21. PMID 10571198.
- ↑ {{cite book |author=Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor) |title=Modern Surgical Pathology (2 Volume Set) |publisher=W B Saunders |location=London |year= |pages= |isbn=0-7216-7253-1 |oclc= |doi=}